Joseph D Fondell

Title: Joseph D Fondell: Innovator in Nuclear Hormone Receptor Research

Introduction

Joseph D Fondell is a prominent inventor based in Baltimore, MD (US). He has made significant contributions to the field of molecular biology, particularly in the study of nuclear hormone receptors. His work has implications for understanding gene regulation and potential therapeutic applications.

Latest Patents

Joseph D Fondell holds a patent for "Nucleic acid molecules encoding nuclear hormone receptor coactivators and uses thereof." This patent includes isolated nucleic acid molecules encoding Thyroid Receptor-Associated Proteins (TRAPS). TRAPS are integral components of protein complexes that interact with nuclear hormone receptors in a ligand-dependent manner. Upon activation by corresponding hormones, these receptors regulate the transcription of specific genes. The patent also outlines methods for replicating and expressing these isolated nucleic acid molecules, as well as pharmaceutical compositions that include TRAPS. Furthermore, it describes methods for modulating gene expression through the administration of therapeutically effective amounts of these compositions.

Career Highlights

Joseph D Fondell is affiliated with The Rockefeller University, where he conducts his research. His work has been pivotal in advancing the understanding of nuclear hormone receptor mechanisms and their role in gene expression.

Collaborations

Joseph has collaborated with notable scientists in his field, including Robert G Roeder and Chao Xingyuan. These collaborations have further enriched his research and contributed to the scientific community's understanding of nuclear hormone receptors.

Conclusion

Joseph D Fondell's innovative research and patent contributions have significantly impacted the field of molecular biology. His work continues to pave the way for advancements in gene regulation and therapeutic applications.